Vivani Medical Announces Publication of Positive Weight Loss Data Supporting Potential Veterinary Use of OKV-119 Miniature, Long-term GLP-1 Implant Data Published in BMC Veterinary Research shows that OKV-119 exenatide implant reduced feline weight Felines share many pathophysiologic obesity phenotypes with humans, further supporting clinical evaluations of miniature, subdermal GLP-1 implants for obesity reduction Development partner, Okava Pharmaceuticals, is studying OKV-119 for the treatment of pre-diabetes, diabetes, and obesity in companion felines ALAMEDA, Calif.--(BUSINESS WIRE)-- Vivani Medical, Inc
The shift isnt going to happen overnight, though
SCFAs as Major Metabolites of Intestinal Bacteria In recent years, studies investigating the interactions between gut microbiota and its host has focused on recognizing an essential factor that influences homeostasis
Pringle S, Maimets M, van der Zwaag M, Stokman MA, van Gosliga D, Zwart E, et al